Moreover, the rationale for exploring the impact of post-natal Gtf2i deletion lies in the potential for developing therapeutic interventions for neurodevelopmental disorders and other pathological conditions beyond current behavioral therapies and pharmaceutical agents. The gene discussed is GTF2I; the disease is neurodevelopmental disorder.